Zelira Therapeutics Ltd has released a press release.
Zelda Granted Approval for Opioid Reduction Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- March 2019 Quarterly Report
- Zelda Partners with Ilera HealthCare
- Aus Patent For Novel Prognostic Marker for Breast Cancer
- Appendix 4D & FY19 Interim Financial Report
- December 2018 Quarterly Report and Board Transition
Later from Zelira Therapeutics
- Response to ASX Price and Volume Query
- Zelda Collaborates with Emerald Clinics
- June 2019 Quarterly Report
- Zeldas Autism Observational Study Recruits 100th Participant
- Zelda to merge with US-based Ilera Therapeutics
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics